Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Fecci Peter E."" wg kryterium: Autor


Wyświetlanie 1-8 z 8
Tytuł:
Inpatient palliative care utilization for patients with brain metastases.
Autorzy:
Price M; Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA.
Howell EP; Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA.
Dalton T; Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA.
Ramirez L; Duke Center for Brain and Spine Metastasis, Duke University Medical Center, Durham, North Carolina, USA.
Howell C; Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.
Williamson T; Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA.
Fecci PE; Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA.
Anders CK; Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.
Check DK; Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.; Department of Population Health Sciences, Duke University Medical Center, Durham, North Carolina, USA.
Kamal AH; Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.; Fuqua School of Business, Duke University, Durham, North Carolina, USA.
Goodwin CR; Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA.
Pokaż więcej
Źródło:
Neuro-oncology practice [Neurooncol Pract] 2021 Feb 24; Vol. 8 (4), pp. 441-450. Date of Electronic Publication: 2021 Feb 24 (Print Publication: 2021).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Health care resource utilization and treatment of leptomeningeal carcinomatosis in the United States.
Autorzy:
Adil SM; Department of Neurosurgery, Duke University Medical Center, Durham, NC, US.
Hodges SE; Department of Neurosurgery, Duke University Medical Center, Durham, NC, US.
Edwards RM; Department of Neurosurgery, Duke University Medical Center, Durham, NC, US.
Charalambous LT; Department of Neurosurgery, Duke University Medical Center, Durham, NC, US.
Yang Z; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, US.
Kiyani M; Department of Neurosurgery, Duke University Medical Center, Durham, NC, US.
Musick A; Department of Neurosurgery, Duke University Medical Center, Durham, NC, US.
Parente BA; Department of Neurosurgery, Duke University Medical Center, Durham, NC, US.
Lee HJ; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, US.
Peters KB; Department of Neurosurgery, Duke University Medical Center, Durham, NC, US.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, US.
Fecci PE; Department of Neurosurgery, Duke University Medical Center, Durham, NC, US.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, US.
Lad SP; Department of Neurosurgery, Duke University Medical Center, Durham, NC, US.
Pokaż więcej
Źródło:
Neuro-oncology practice [Neurooncol Pract] 2020 Jul 21; Vol. 7 (6), pp. 636-645. Date of Electronic Publication: 2020 Jul 21 (Print Publication: 2020).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
The intersection between immunotherapy and laser interstitial thermal therapy: a multipronged future of neuro-oncology.
Autorzy:
Srinivasan ES; Department of Neurosurgery, Duke University School of Medicine, Durham, NC, USA.
Sankey EW; Department of Neurosurgery, Duke University School of Medicine, Durham, NC, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.
Grabowski MM; Department of Neurosurgery, Cleveland Clinic, Cleveland, OH, USA.
Chongsathidkiet P; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.
Fecci PE; Department of Neurosurgery, Duke University School of Medicine, Durham, NC, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.
Pokaż więcej
Źródło:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2020 Jul; Vol. 37 (2), pp. 27-34.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Brain Neoplasms*/therapy
Hyperthermia, Induced*
Immunotherapy*
Laser Therapy*
Humans ; Lasers ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Operative and peri-operative considerations in the management of brain metastasis.
Autorzy:
Sankey EW; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.
Tsvankin V; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.
Grabowski MM; Department of Neurosurgery, Cleveland Clinic, Cleveland, OH, USA.
Nayar G; Department of Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Batich KA; Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Risman A; School of Medicine, Medical College of Georgia, Augusta, GA, USA.
Champion CD; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.
Salama AKS; Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA.
Goodwin CR; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.
Fecci PE; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2019 Nov; Vol. 8 (16), pp. 6809-6831. Date of Electronic Publication: 2019 Sep 30.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Brain Neoplasms/*therapy
Brain Neoplasms/secondary ; Combined Modality Therapy ; Humans ; Perioperative Period
Czasopismo naukowe
Tytuł:
Predicting intracranial progression following stereotactic radiosurgery for brain metastases: Implications for post SRS imaging.
Autorzy:
Natarajan BD; Department of Radiation Oncology, Duke University, Durham, NC, USA.
Rushing CN; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.
Cummings MA; Department of Radiation Oncology, University of Rochester, Rochester, NY, USA.
Jutzy JM; Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA.
Choudhury KR; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.
Moravan MJ; Department of Radiation Oncology, Duke University, Durham, NC, USA.
Fecci PE; Department of Neurosurgery, Duke University, Durham, NC, USA.
Adamson J; Department of Radiation Oncology, Duke University, Durham, NC, USA.
Chmura SJ; Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA.
Milano MT; Department of Radiation Oncology, University of Rochester, Rochester, NY, USA.
Kirkpatrick JP; Department of Radiation Oncology, Duke University, Durham, NC, USA.
Salama JK; Department of Radiation Oncology, Duke University, Durham, NC, USA.
Pokaż więcej
Źródło:
Journal of radiosurgery and SBRT [J Radiosurg SBRT] 2019; Vol. 6 (3), pp. 179-187.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Are BiTEs the "missing link" in cancer therapy?
Autorzy:
Suryadevara CM; Duke Brain Tumor Immunotherapy Program; Division of Neurosurgery; Department of Surgery; Duke University Medical Center ; Durham, NC, USA ; Department of Pathology; Duke University Medical Center ; Durham, NC, USA ; The Preston Robert Tisch Brain Tumor Center; Duke University Medical Center ; Durham, NC, USA.
Gedeon PC; Duke Brain Tumor Immunotherapy Program; Division of Neurosurgery; Department of Surgery; Duke University Medical Center ; Durham, NC, USA ; The Preston Robert Tisch Brain Tumor Center; Duke University Medical Center ; Durham, NC, USA ; Department of Biomedical Engineering; Duke University ; Durham, NC, USA.
Sanchez-Perez L; Duke Brain Tumor Immunotherapy Program; Division of Neurosurgery; Department of Surgery; Duke University Medical Center ; Durham, NC, USA ; The Preston Robert Tisch Brain Tumor Center; Duke University Medical Center ; Durham, NC, USA.
Verla T; Duke Brain Tumor Immunotherapy Program; Division of Neurosurgery; Department of Surgery; Duke University Medical Center ; Durham, NC, USA ; The Preston Robert Tisch Brain Tumor Center; Duke University Medical Center ; Durham, NC, USA.
Alvarez-Breckenridge C; Department of Neurosurgery; Massachusetts General Hospital and Harvard Medical School ; Boston, MA, USA.
Choi BD; Department of Neurosurgery; Massachusetts General Hospital and Harvard Medical School ; Boston, MA, USA.
Fecci PE; Duke Brain Tumor Immunotherapy Program; Division of Neurosurgery; Department of Surgery; Duke University Medical Center ; Durham, NC, USA ; The Preston Robert Tisch Brain Tumor Center; Duke University Medical Center ; Durham, NC, USA.
Sampson JH; Duke Brain Tumor Immunotherapy Program; Division of Neurosurgery; Department of Surgery; Duke University Medical Center ; Durham, NC, USA ; Department of Pathology; Duke University Medical Center ; Durham, NC, USA ; The Preston Robert Tisch Brain Tumor Center; Duke University Medical Center ; Durham, NC, USA ; Department of Biomedical Engineering; Duke University ; Durham, NC, USA.
Pokaż więcej
Źródło:
Oncoimmunology [Oncoimmunology] 2015 Apr 30; Vol. 4 (6), pp. e1008339. Date of Electronic Publication: 2015 Apr 30 (Print Publication: 2015).
Typ publikacji:
Review; Journal Article
Czasopismo naukowe
Tytuł:
Immunovirotherapy for the treatment of glioblastoma.
Autorzy:
Cheema TA; Brain Tumor Research Center; Department of Neurosurgery; Massachusetts General Hospital and Harvard Medical School; Boston, MA USA ; Momenta Pharmaceuticals; Cambridge, MA USA.
Fecci PE; Brain Tumor Research Center; Department of Neurosurgery; Massachusetts General Hospital and Harvard Medical School; Boston, MA USA.
Ning J; Brain Tumor Research Center; Department of Neurosurgery; Massachusetts General Hospital and Harvard Medical School; Boston, MA USA.
Rabkin SD; Brain Tumor Research Center; Department of Neurosurgery; Massachusetts General Hospital and Harvard Medical School; Boston, MA USA.
Pokaż więcej
Źródło:
Oncoimmunology [Oncoimmunology] 2014 Jan 01; Vol. 3 (1), pp. e27218.
Typ publikacji:
Journal Article
Czasopismo naukowe
    Wyświetlanie 1-8 z 8

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies